G6PD deficiency: its role in the high prevalence of hypertension and diabetes mellitus
This corresponded to a NNH of 1,198, indicating that approximately one additional case of psoriasis would occur for every 1,200 patients treated with GLP-1 RAs instead of DPP-4is
Wegovy is the brand name for semaglutide at the 2.4 mg dose, made by Novo Nordisk
In this post, we'll deep dive into the discussion around GLP-1s and eating disorders, to ensure that employers, providers and health plans have access to the right support for members on GLP-1s
Referral to specialist weight management services may benefit patients experiencing persistent plateaus or those with complex obesity requiring multidisciplinary input
Stopping cold turkey is not recommended